Diabetes Risk: Can In Utero Exposure to Environmental Toxins Like PAHs Increase Susceptibility?
"New research explores how exposure to polycyclic aromatic hydrocarbons (PAHs) during fetal development could influence the likelihood of developing diabetes later in life."
A recent study published in Diabetes & Metabolism Journal has sparked interest in the potential link between in utero exposure to polycyclic aromatic hydrocarbons (PAHs) and an increased susceptibility to diabetes. PAHs are a group of chemicals formed during the incomplete burning of coal, oil, gas, wood, and other organic substances. They are common environmental pollutants found in air, water, and soil.
The study aimed to determine if exposure to PAHs during fetal development could make offspring more vulnerable to developing diabetes. Researchers focused on how 2-aminoanthracene (2-AA), a type of PAH, impacts various factors related to diabetes development. These factors included weight gain, serum glucose levels, adipose tissue characteristics, inflammation, and specific cell staining.
To evaluate the effects of in utero 2-AA exposure, the researchers monitored the weight of rats. They tracked weight changes for nearly three months before introducing a moderate high-fat diet. The findings revealed notable trends, particularly in the low-dose exposure group, suggesting potential long-term impacts on metabolic health.
Population Studies on PAHs and Diabetes
A 2024 study used data from 7,849 people aged 20 years or older to examine whether high PAH exposure was associated with diabetes and stroke in the general population. Its authors describe the work as an effort to clarify PAHs’ effects on those outcomes. A separate analysis examined the association between urinary PAHs and diabetes mellitus using U.S. National Health and Nutrition Examination Survey data from 2003–2016.
Exposure Biomarkers and Risk Models
Studies have assessed PAH exposure using urinary metabolites, including eight urinary monohydroxy-PAHs measured among participants in merged NHANES 2001–2006. One study reported a modest improvement in diabetes discrimination when certain PAH metabolites were added to conventional risk factors, and suggested a possible dose-dependent relationship in a general Chinese population. Another reported that high PAH exposure may indirectly contribute to diabetes risk in connection with dyslipidemia; it also found that BMI, hypertension, and triglycerides mediated 89.1% of the effect of low socioeconomic status on diabetes. Animal studies have linked PAHs to inflammation and subsequent diabetes development, but these findings do not by themselves establish the same pathway in humans.
Evidence Across Exposure Settings
A 2022 review of urinary PAH studies reported that, among coke oven workers, 4-hydroxyphenanthrene (4-OHPh) was significantly correlated with increased diabetes risk. The same review emphasized that exposure measurements, outcome definitions, and confounder adjustments varied across studies. It characterized the overall results as indicating a potentially adverse effect of PAHs on diabetes, while noting that the evidence was heterogeneous.
Key Findings: How Does In Utero PAH Exposure Affect Diabetes Risk?
The researchers assessed several parameters to understand how in utero PAH exposure influences diabetes susceptibility:
- Adipose Tissue Analysis: The study examined adipose tissue (AT) histology and size, CD68+ specific staining, and inflammatory gene expression. CD68 is a marker for macrophages, immune cells involved in inflammation.
- CD68+ Cells and Inflammation: In young rats, CD68+ cell levels in AT were not significantly different between groups. However, low-dose animals showed slightly higher levels, while the high-dose group showed slightly fewer CD68+ cells. Older rats exposed to 2-AA and a moderate high-fat diet had slightly greater CD68+ cell quantities than control groups, though not significantly.
- Macrophage Distribution: Young rats had macrophages between adipocytes, forming loose aggregates around capillaries. This feature was less common in older pups, indicating a normal aging change in macrophage distribution.
Recent Research and Mixed Findings
A study published in 2026 describes PAHs as widespread environmental pollutants with potential endocrine-disrupting effects. It notes that earlier epidemiological research on PAHs and insulin resistance has produced inconsistent results. A separate study framed diabetes as a possible mediator in associations between PAH exposure and cardiovascular disease, with the aim of clarifying the effects of high PAH exposure on diabetes and stroke in the general population.
Heterogeneity Limits Comparisons
A review of studies on urinary PAHs and diabetes reported substantial differences in exposure measurements, outcome definitions, and adjustment for confounders. These differences make direct comparisons across studies difficult and temper conclusions about the consistency of the association. The review therefore identifies variability in study methods as an important limitation of the evidence.
Diabetes Research in Children
A 2016 study on susceptibility to diabetes noted an increase in the incidence of type 2 diabetes mellitus (T2DM), particularly among children. The available source description does not report the study’s methods, findings, or any comparison with prenatal PAH exposure. It therefore provides context about pediatric T2DM incidence but does not establish whether in utero toxin exposure affects susceptibility.
What Does This Mean for You?
While this research is still in its early stages, it highlights the importance of reducing exposure to environmental toxins, especially during pregnancy. Although the study focused on rats, the findings suggest that in utero exposure to PAHs could potentially increase the risk of diabetes in humans. Further research is needed to fully understand the implications, but being mindful of environmental exposures and promoting a healthy lifestyle can contribute to better health outcomes for both mothers and their children.
Clarifying PAH Effects on Diabetes and Stroke
A 2024 study set out to clarify the effect of high PAH exposure on diabetes and stroke in the general population. Its rationale notes epidemiological evidence linking PAH exposure with cardiovascular disease and identifies diabetes as a common cardiovascular disease risk factor. The study’s stated aim points to further investigation of how PAH exposure, diabetes, and stroke may be related; the source description does not provide a definitive conclusion about those effects.